Breaking the Silence: Addressing Women’s Hair Loss in the Philippines

Breaking the Silence: Trinoxteride Tackles Women’s Hair Loss Stigma in the Philippines

MANILA, Philippines — In a groundbreaking initiative, hair growth product brand Trinoxteride convened 13 licensed medical doctors and industry experts for a roundtable discussion aimed at addressing a pressing yet often overlooked issue: the stigma surrounding women’s hair loss in the Philippines.

While conversations about hair loss have become increasingly open among men, many Filipina women still find it challenging to discuss early signs of thinning, shedding, or alopecia. This silence not only delays treatment but also exacerbates the emotional and physical toll of hair loss. The recent event sought to create a safe space for dialogue and education, breaking down barriers that prevent women from seeking help.

The roundtable also marked the soft launch of the Trinoxteride Hair Loss Preventive System, a three-step regimen designed for men, women, and even children to combat early-stage hair fall. At the heart of this innovative system is Redensyl, a new generation, plant-based compound supported by global clinical research.

Ramon Natcher, CEO of Trinoxteride, emphasized the brand’s mission to introduce science-backed, effective, and safer alternatives to the Philippine hair-care market. “We want to make preventive hair care accessible, safe, and backed by real science,” he stated, highlighting Redensyl as a breakthrough ingredient that combines the effectiveness of traditional treatments with a gentle, non-irritating formula suitable for a wide range of consumers.

During the discussion, dermatologists and medical professionals reviewed clinical studies on Redensyl, revealing its significant effectiveness in stimulating hair growth and reducing hair fall. Key findings included:

• Effectiveness: Redensyl shows strong potential as an alternative to commonly used topical treatments.
• Gentle Formula: Being plant-based and non-hormonal, it results in minimal to no side effects.
• Broad Applicability: Safe for use by men, women, pregnant women (with medical guidance), and children, as it contains no harsh chemicals.

The attending physicians expressed robust support for the product, recognizing it as a science-backed option that fills a crucial gap for patients seeking gentle yet effective solutions.

Adding a personal touch to the event, Miss Universe Philippines – Baguio 2025, Gwendoline Meliz Soriano, shared her own experience with alopecia areata during her pageant journey. Her testimony highlighted the emotional challenges of sudden hair loss and underscored the importance of early detection, accessible treatment options, and open conversations—especially for women who often feel pressured by societal beauty standards.

Soriano’s presence reinforced the necessity of normalizing discussions about hair loss as a legitimate health concern rather than a source of shame. As the roundtable concluded, it became clear that initiatives like Trinoxteride’s are essential in fostering a supportive environment where women can openly address their hair loss concerns and seek the help they deserve.

With the launch of the Trinoxteride Hair Loss Preventive System, the brand is not just offering a product; it is championing a movement towards acceptance and proactive care in the realm of women’s health.